AI Proteins
LightNews LightNews
banner
aiproteins.com
AI Proteins
@aiproteins.com
130 followers 11 following 13 posts
The perfect medicine is not found

https://aiproteins.com
Posts Replies Media Videos
Reposted by AI Proteins
cdbahl.com
Thanks for the fun conversation Ingmar Schuster, and for the opportunity to share more about what we're building at @aiproteins.com!

youtu.be/7O0s5AY46U0
Chris Bahl on the Conundrum of Biotech Platforms
YouTube video by Provolut
youtu.be
November 21, 2025 at 8:18 PM
aiproteins.com
AI Proteins has closed a $41.5 million Series A financing to accelerate the development of de novo #miniproteins! The round was led by Mission BioCapital and SANTÉ, with robust participation from existing investors.

See the official press release for details:
www.businesswire.com/news/home/20...
November 20, 2025 at 8:02 PM
Reposted by AI Proteins
cdbahl.com
The next chapter for AI Proteins @aiproteins.com is officially underway! I'm absolutely delighted to share that we’ve closed a $41.5M Series A led by Mission BioCapital and Santé Ventures.

endpoints.news/boston-biote...
Exclusive: AI Proteins raises $42M Series A, and will launch miniproteins into hub-and-spoke model
AI Proteins raises $42M Series A for minibinder drug development, led by Mission BioCapital & Santé Ventures. CEO Chris Bahl aims to target TNFR1 with first candidate.
endpoints.news
November 18, 2025 at 3:55 PM
Reposted by AI Proteins
cdbahl.com
This is the foundation for our next chapter at @aiproteins.com. We’ve industrialized the process of creating #miniproteins de novo while fully controlling every aspect of their activity and properties.
November 11, 2025 at 5:06 PM
Reposted by AI Proteins
cdbahl.com
My new @ted.com talk from the main stage just went live!

go.ted.com/chrisbahl

🧵👇
The secret language of cells — and how to "speak" it
What if medicines could "speak" directly to your cells? Protein designer and TED Fellow Chris Bahl introduces a new generation of miniproteins: AI-designed medicines that can deliver detailed instruct...
go.ted.com
November 11, 2025 at 5:06 PM
aiproteins.com
We're #hiring a Scientist in Mass Spectrometry!

Apply today or share this post with your network: www.linkedin.com/jobs/view/42...
(ignore what linkedin says - the search is still open)

Interested? Please email your CV to: [email protected]
AI Proteins hiring Scientist in Mass Spectrometry Miniproteins and Bioconjugates in Greater Boston | LinkedIn
Posted 8:20:30 PM. The Company:AI Proteins is a Boston-based biotechnology company focused on the de novo design and…See this and similar jobs on LinkedIn.
www.linkedin.com
September 3, 2025 at 5:44 PM
aiproteins.com
Congratulations to Dr. James Bowman on his promotion to Chief Technology Officer!

www.businesswire.com/news/home/20...
www.businesswire.com
August 26, 2025 at 2:39 PM
Reposted by AI Proteins
cdbahl.com
I am overjoyed to announce that James Bowman has been promoted to Chief Technology Officer at @aiproteins.com!

🧵👇
August 26, 2025 at 2:17 PM
Reposted by AI Proteins
ipiproteins.bsky.social
#IPISeminar alert 🔔 Friday at 2 p.m. ET, Chris Bahl of AI Proteins will share the challenges of incorporating #artificialintelligence into #proteindesign & the impact reimagined #miniproteins can have on therapeutics. Join us through the QR code or follow the Zoom link on our calendar! rb.gy/xcee9l
May 1, 2025 at 2:08 PM
Reposted by AI Proteins
cdbahl.com
It was an honor to speak from the main stage at TED last week about our work at AI Proteins

Our mission is to design the next generation of therapeutics built from de novo #miniproteins, and this was an unbelievable opportunity to help shape the broader conversation about the future of biologics
April 15, 2025 at 4:26 PM
aiproteins.com
Welcome Phil Brandish, Chief Development Officer, to the AI Proteins team!

www.businesswire.com/news/home/20...
AI Proteins Appoints Philip E. Brandish, PhD as Chief Development Officer
AI Proteins, Inc., a pioneering company utilizing artificial intelligence to design novel miniprotein therapeutics, today announced the appointment of
www.businesswire.com
February 12, 2025 at 4:48 PM
aiproteins.com
We're delighted to share that our #Founder Chris Bahl @cdbahl.bsky.social is now our CEO!
January 7, 2025 at 2:16 PM
Reposted by AI Proteins
cdbahl.com
So, I might have ended up on the jumbotron at the Celtics game proudly wearing my @aiproteins.bsky.social colors
December 20, 2024 at 3:17 AM
aiproteins.com
Mireia Solà Colom, Head of Immunotherapeutics at AI Proteins, presents our latest progress on the design and optimization of immune cell engagers built from our de novo #miniproteins
bpdmc.org Boston Protein Design and Modeling Club @bpdmc.org · Dec 16
for the folks who weren't able to join for the brilliant presentation by Mireia Solà Colom last week to cap off our 2024 seminar series, you can check out the recording 👇
youtu.be/e6oZgGWjD_0
De novo design of miniprotein-based natural killer cell engagers
YouTube video by Boston Protein Design and Modeling Club
youtu.be
December 17, 2024 at 9:26 PM
Reposted by AI Proteins
mellases.bsky.social
Exciting times at @aiproteins.bsky.social ! We are getting so close to see our drugs helping patients!
www.fiercebiotech.com/biotech/bris...
Bristol Myers Squibb taps AI Proteins in drug discovery collaboration worth up to $400M
Bristol Myers Squibb has
www.fiercebiotech.com
December 3, 2024 at 7:48 PM
aiproteins.com
AI Proteins is excited to partner with @bms-news.bsky.social to develop novel miniprotein-based therapeutics. This collaboration will leverage our cutting-edge AI-driven platform to design and optimize miniproteins with the potential to transform patient outcomes
www.businesswire.com/news/home/20...
AI Proteins Announces Research Collaboration and Option Agreement with Bristol Myers Squibb for Miniprotein-Based Therapeutics Valued up to $400M
AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, today announced that
www.businesswire.com
December 3, 2024 at 5:30 PM
Reposted by AI Proteins
cdbahl.com
We've got some very exciting news to share!

businesswire.com/news/home/20...

and here's a 🧵 about the journey from academia to
@aiproteins.bsky.social
AI Proteins Announces Research Collaboration and Option Agreement with Bristol Myers Squibb for Miniprotein-Based Therapeutics Valued up to $400M
AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, today announced that
businesswire.com
December 3, 2024 at 2:49 PM
aiproteins.com
We're excited that Mireia Solà Colom, our Head of Immunotherapeutics will share some of our latest work on immune cell engagers at @bpdmc.bsky.social next month!
bpdmc.org Boston Protein Design and Modeling Club @bpdmc.org · Nov 22
There's just one meeting left in 2024, and we have a spectacular seminar by Mireia Solà Colom lined up for you! Join us at 7pm in Room 181, Building 68, MIT on Wednesday, December 11th.

"De novo design of miniprotein-based natural killer cell engagers"

See you there & Happy Thanksgiving!
bpdmc.org
schedule
introduction and membership Boston Protein Design and Modeling Club (BPDMC) is a community of computational protein engineers and modelers from both academia and industry. While we are based in Boston...
bpdmc.org
November 25, 2024 at 1:33 PM
aiproteins.com
Our founder, President and CSO Chris Bahl @cdbahl.bsky.social went to the Falling Walls Science Summit last week to explain how we make #miniprotein therapeutics with unprecedented ability to control cellular behavior - you can check out the recording 👇
www.youtube.com/live/zB6-iUB...
YouTube
Share your videos with friends, family, and the world
www.youtube.com
November 16, 2024 at 6:25 PM